Corbion N.V. (CSU) - Total Liabilities
Based on the latest financial reports, Corbion N.V. (CSU) has total liabilities worth €674.30 Million EUR (≈ $788.33 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Corbion N.V. (CSU) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Corbion N.V. - Total Liabilities Trend (2018–2025)
This chart illustrates how Corbion N.V.'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see CSU total assets.
Corbion N.V. Competitors by Total Liabilities
The table below lists competitors of Corbion N.V. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Corvus Pharmaceuticals Inc
NASDAQ:CRVS
|
USA | $13.95 Million |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥86.13 Million |
|
Beijing Sojo Electric Co Ltd
SHE:300444
|
China | CN¥6.57 Billion |
|
Jiangsu Zhengdan Chemical Industry Co Ltd
SHE:300641
|
China | CN¥116.06 Million |
|
MoonLake Immunotherapeutics
NASDAQ:MLTX
|
USA | $146.35 Million |
|
Shanghai Prisemi Electronics Co Ltd
SHG:688230
|
China | CN¥58.91 Million |
|
Hangzhou Greenda Electronic Materials Co Ltd
SHG:603931
|
China | CN¥179.16 Million |
|
Highpeak Energy Acquisition Corp
NASDAQ:HPK
|
USA | $1.62 Billion |
Liability Composition Analysis (2018–2025)
This chart breaks down Corbion N.V.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Corbion N.V. net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.91 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Corbion N.V.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Corbion N.V. (2018–2025)
The table below shows the annual total liabilities of Corbion N.V. from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €674.30 Million ≈ $788.33 Million |
-12.86% |
| 2024-12-31 | €773.80 Million ≈ $904.65 Million |
-26.35% |
| 2023-12-31 | €1.05 Billion ≈ $1.23 Billion |
-2.70% |
| 2022-12-31 | €1.08 Billion ≈ $1.26 Billion |
+37.19% |
| 2021-12-31 | €787.00 Million ≈ $920.09 Million |
+40.91% |
| 2020-12-31 | €558.50 Million ≈ $652.95 Million |
-0.62% |
| 2019-12-31 | €562.00 Million ≈ $657.04 Million |
+26.12% |
| 2018-12-31 | €445.60 Million ≈ $520.95 Million |
-- |
About Corbion N.V.
Corbion N.V. provides lactic acid and derivatives, food preservation solutions, functional ingredient systems, and algae-derived nutritional ingredients in the Netherlands, the United States, Asia, rest of Americas, the rest of Europe, the Middle East, and Africa. It operates in two segments, Functional Ingredients & Solutions, and Health & Nutrition. The company offers antioxidants, fermentation… Read more